CRIS Current Research Information System

DOMENICALI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.241
AS - Asia 9.192
EU - Europa 6.212
SA - Sud America 549
AF - Africa 451
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 25.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.140
VN - Vietnam 2.798
SG - Singapore 2.261
CN - Cina 2.101
IT - Italia 1.385
GB - Regno Unito 1.244
HK - Hong Kong 819
SE - Svezia 693
DE - Germania 677
FR - Francia 430
BR - Brasile 379
IN - India 355
RU - Federazione Russa 296
NL - Olanda 235
IE - Irlanda 229
UA - Ucraina 219
CH - Svizzera 194
KR - Corea 153
ZA - Sudafrica 145
JP - Giappone 140
TG - Togo 127
FI - Finlandia 108
BG - Bulgaria 100
EE - Estonia 94
CI - Costa d'Avorio 87
JO - Giordania 77
AT - Austria 72
AR - Argentina 67
TH - Thailandia 67
PH - Filippine 62
ES - Italia 61
CA - Canada 57
BD - Bangladesh 51
ID - Indonesia 45
IR - Iran 41
PL - Polonia 41
TR - Turchia 37
EC - Ecuador 35
BE - Belgio 34
MX - Messico 31
SC - Seychelles 29
CL - Cile 28
IQ - Iraq 28
PK - Pakistan 23
SA - Arabia Saudita 21
TW - Taiwan 20
AU - Australia 19
GR - Grecia 19
UZ - Uzbekistan 19
CO - Colombia 16
HR - Croazia 14
MA - Marocco 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
LB - Libano 11
LT - Lituania 11
MY - Malesia 11
RO - Romania 10
ET - Etiopia 9
IL - Israele 9
NG - Nigeria 9
TN - Tunisia 9
PY - Paraguay 7
VE - Venezuela 7
EG - Egitto 6
NP - Nepal 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
AZ - Azerbaigian 4
DK - Danimarca 4
DZ - Algeria 4
LV - Lettonia 4
MU - Mauritius 4
NO - Norvegia 4
PT - Portogallo 4
XK - ???statistics.table.value.countryCode.XK??? 4
DO - Repubblica Dominicana 3
GH - Ghana 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MN - Mongolia 3
OM - Oman 3
PS - Palestinian Territory 3
BO - Bolivia 2
EU - Europa 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SI - Slovenia 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 25.655
Salva come PNG Salva come JPEG
Città #
Singapore 1.507
Southend 1.064
Ashburn 984
Fairfield 874
Hong Kong 765
Chandler 699
Ho Chi Minh City 569
Hanoi 518
Santa Clara 498
San Jose 490
Dong Ket 470
Woodbridge 445
Hefei 370
Seattle 369
Houston 363
Wilmington 363
Bologna 358
Cambridge 322
Princeton 273
Beijing 245
Ann Arbor 236
Dublin 227
Boardman 223
Bern 178
Los Angeles 169
Lauterbourg 150
Seoul 131
Lomé 126
Council Bluffs 122
Jacksonville 121
Nanjing 115
Tokyo 114
Westminster 107
Dallas 106
Milan 100
Sofia 99
Padova 97
Da Nang 93
Abidjan 87
New York 82
Berlin 81
Amman 76
Helsinki 75
Haiphong 70
Munich 66
Buffalo 64
San Diego 63
Turin 61
Florence 60
Jinan 60
Saint Petersburg 60
Shenyang 60
Shanghai 56
Guangzhou 53
Redondo Beach 50
Vienna 48
Frankfurt am Main 46
Changsha 44
Hebei 40
Tianjin 39
Bengaluru 38
São Paulo 35
Hải Dương 34
Johannesburg 34
Amsterdam 33
Nuremberg 32
London 31
Brussels 30
Chicago 30
Redmond 30
Rome 30
Bangkok 29
Dearborn 29
Mülheim 29
Nanchang 29
Paris 29
Biên Hòa 26
Can Tho 26
Jakarta 24
Warsaw 24
Falkenstein 23
Jiaxing 23
Medford 23
Norwalk 23
Orem 23
Zhengzhou 23
Bremen 21
Hangzhou 21
Thái Nguyên 21
Düsseldorf 20
Redwood City 20
San Francisco 20
Barcelona 19
Montreal 19
Ningbo 19
Olalla 19
Phoenix 19
Atlanta 18
Shenzhen 18
The Dalles 18
Totale 16.413
Salva come PNG Salva come JPEG
Nome #
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 292
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 260
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 252
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 249
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 246
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 239
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 238
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 232
Ethical and legal implications of health monitoring wearable devices: A scoping review 228
A novel model of CCl4-induced cirrosi with ascites in the mouse. 222
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 220
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 216
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 216
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 216
Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation 215
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 215
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 213
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 212
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 209
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 204
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 203
Clinical indications for the albumin use: Still a controversial issue. 203
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 201
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 199
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 198
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 197
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 197
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 196
Mortality and its association with chronic alcohol-related diseases in patients admitted to the emergency department for acute alcoholic intoxication: retrospective cohort study 194
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 194
Metabolic disorders across hepatocellular carcinoma in Italy 193
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 192
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 192
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET) 191
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 188
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 187
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 186
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 186
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 185
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 185
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 185
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 185
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 184
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 182
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 181
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 180
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 177
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 176
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 175
QT Interval Correction in Patients with Cirrhosis 175
Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute dcompensation of cirrhosis. 174
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 173
Predictors of clinical trajectories of patients with acutely decompensated cirrhosis. An external validation of the PREDICT study 171
Effect of the cannabinoid CB1 receptor antagonist SR141716 in a rat model of liver inflammation 171
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 170
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 170
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 170
Development and validation of a scoring system that includes corrected QT interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding 168
Dorsal acoustic windows may ameliorate liver ultrasound in patients with liver disease and meteorism/obesity/ascites. 166
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 166
The endocannabinoid system and liver diseases. 165
null 164
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 164
Gioco responsabile e comportamenti di salute: un progetto di ricerca e intervento in Emilia-Romagna 164
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 162
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 161
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 161
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 160
Transthoracic electrical bioimpedance: a non-invasive technique for the evaluation of the hemodynamic alterations in patients with liver cirrhosis. 159
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 158
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 157
A brief up-date of the use of sodium exybate for the treatment of alcohol use disorders. 156
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 156
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 156
Years of life that could be saved from prevention of hepatocellular carcinoma. 155
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 155
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 151
Successful treatment of CCL4-induced acute liver failure with portal vein arterialization in the rat. 150
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 150
Increased anandamide-induced relaxation in mesenteric arteries of cirrhotic rats. Role of cannabinoid and vanilloid receptors. 149
Wearable sensors for monitoring caregivers of people with dementia: a scoping review 148
Hyposplenism as a cause of pneumococcal meningoencephalitis in an adult patient with coeliac disease 148
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 148
A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic 148
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 147
QT interval in patients with cirrhosis: failure of Bazett’s correction and identification of a disease-specific formula. 147
L’apparato cardiovascolare dell’anziano. 146
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) 145
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: The Bagnacavallo Study 145
The renin-angiotensin-aldosterone system in cirrhosis. 144
Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population? 144
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence. 143
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study 143
null 142
Real-world experience with long-term albumin in patients with cirrhosis and ascites 141
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 141
Totale 18.409
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.401
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021952 0 0 0 0 0 0 0 0 0 101 99 752
2021/20222.721 278 94 140 219 204 136 100 174 114 192 676 394
2022/20233.085 280 455 163 365 192 228 89 182 528 70 243 290
2023/20241.050 69 153 91 95 74 200 55 87 46 66 77 37
2024/20253.946 127 567 333 305 689 196 175 85 88 305 187 889
2025/20269.007 739 783 833 718 936 497 1.422 390 1.958 731 0 0
Totale 26.185